Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor + G-CSF vs G-CSF for Stem Cell Mobilization in MM
NCT01301963Phase 3Terminated
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jul 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of plerixafor in multiple myeloma (MM), sponsored by Case Comprehensive Cancer Center. Started Jul 2011; status: terminated.
02
Drugs
plerixafor
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01301963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01301963.